Oxford BioTherapeutics

Oxford BioTherapeutics is a company listed under the stock ticker OXB (GB).

View the org chart displaying its 10 main executives

Most searched biographies at Oxford BioTherapeutics

• Christian Rohlff, Chief Executive Officer
• Jason Gould, Non-Executive Director
• Jean-Pierre Bizzari, Non-Executive Director

Create your alert
to follow the executive moves at Oxford BioTherapeutics.

Oxford BioTherapeutics has 2,273 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Oxford BioTherapeutics

• Immunotherapies Expose and Exploit Cancer’s Varied Weaknesses
• www.oxfordbiotherapeutics.com/news.html

Social media about Oxford BioTherapeutics

• Oxford BioTherapeutics on Wikipedia, Google News & Yahoo Finance
• Oxford BioTherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Christian Rohlff

Call Oxford BioTherapeutics at +44 12...

View the org chart

Register to receive your alert

Report an error